BIOMAT Database Logo BIOMAT Database Logo

BCG vaccine therapy for treatment of superficial bladder cancer. 1989

C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
Department of Immunology, Research Institute of Infectious and Parasitic Disease, Sofia, Bulgaria.

A total of 42 patients were involved in the study of the effectiveness of BCG vaccine on superficial bladder tumours. The new Bulgarian vaccine CALGEVAX was administered intravesically in consecutive instillations once weekly and then once monthly for a period of 11 months. For intradermal application the F-70 subcellular preparation was used. On the grounds of their initial experience in the treatment of superficial bladder tumours with unspecific immunotherapy the authors would like to express their confidence in the effectiveness of the intravesical application of BCG vaccine.

UI MeSH Term Description Entries
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
BCG vaccine in superficial bladder cancer.
March 1994, BMJ (Clinical research ed.),
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
[Intravesical BCG therapy for superficial bladder cancer].
September 1998, Hinyokika kiyo. Acta urologica Japonica,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
BCG therapy for superficial bladder cancer: fundamental aspects.
January 1991, In vivo (Athens, Greece),
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
BCG immunotherapy for superficial bladder cancer.
March 2001, Journal of the Royal Society of Medicine,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
BCG immunotherapy for superficial bladder cancer.
June 2001, Journal of the Royal Society of Medicine,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
[The use of BCG vaccine for preventing recurrences of superficial bladder cancer].
January 1996, Urologiia i nefrologiia,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
BCG and the treatment of superficial bladder cancer.
December 1991, DICP : the annals of pharmacotherapy,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
[Repeated yearly BCG treatment in superficial bladder cancer].
March 1989, Orvosi hetilap,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
BCG therapy of superficial bladder tumors.
January 1989, Progress in clinical and biological research,
C Damianov, and T Patrashkov, and T Tonchev, and A Engibarov, and V Kasabov, and M Chouchkova
Role of fibronectin in intravesical BCG therapy for superficial bladder cancer.
February 1988, The Journal of urology,
Copied contents to your clipboard!